LIVING TO 150? Inside the AI-powered bet on human longevity
retained text
Insilico Medicine is using generative AI to discover and develop new drugs, with over 40 candidates in its pipeline. One of their AI-developed drugs, targeting pulmonary fibrosis, has already reached Phase 3 clinical trials. What’s really interesting is their work on reversing aspects of biological aging. They’re using AI and biological aging clocks to measure whether treatments can actually reverse age-related decline. We’re potentially watching AI accelerate drug discovery while opening the door to treatments that target aging itself. Pretty exciting stuff.
document fetched 2026-10-21 00:29 · canonical https://reddit.com/r/singularity/comments/1xajjao/living_to_150_inside_the_aipowered_bet_on_human